DA-4001C
DA4001_AGAP_POC
Phase 2 small_molecule completed
Quick answer
DA-4001C for Androgenetic Alopecia is a Phase 2 program (small_molecule) at Dong Wang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dong Wang
- Indication
- Androgenetic Alopecia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed